CX Institutional purchased a new position in shares of Cardinal Health, Inc. (NYSE:CAH – Free Report) during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund purchased 2,256 shares of the company’s stock, valued at approximately $267,000.
Several other institutional investors also recently modified their holdings of CAH. Eastern Bank acquired a new position in shares of Cardinal Health during the 3rd quarter worth about $25,000. Frazier Financial Advisors LLC increased its stake in shares of Cardinal Health by 69.8% during the 3rd quarter. Frazier Financial Advisors LLC now owns 253 shares of the company’s stock worth $28,000 after purchasing an additional 104 shares during the last quarter. Hara Capital LLC acquired a new position in shares of Cardinal Health during the 3rd quarter worth about $31,000. AM Squared Ltd acquired a new position in shares of Cardinal Health during the 3rd quarter worth about $33,000. Finally, Carolina Wealth Advisors LLC acquired a new position in shares of Cardinal Health during the 3rd quarter worth about $47,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.
Cardinal Health Price Performance
Shares of NYSE:CAH opened at $128.89 on Monday. The company has a market cap of $31.19 billion, a price-to-earnings ratio of 25.08, a PEG ratio of 1.57 and a beta of 0.63. The firm has a 50 day simple moving average of $121.36 and a 200 day simple moving average of $113.16. Cardinal Health, Inc. has a one year low of $93.17 and a one year high of $129.68.
Cardinal Health Cuts Dividend
The firm also recently declared a quarterly dividend, which was paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd were given a $0.5056 dividend. This represents a $2.02 annualized dividend and a yield of 1.57%. The ex-dividend date of this dividend was Thursday, January 2nd. Cardinal Health’s dividend payout ratio (DPR) is currently 39.30%.
Analyst Upgrades and Downgrades
A number of research analysts recently commented on the stock. Barclays upped their price target on shares of Cardinal Health from $117.00 to $133.00 and gave the company an “overweight” rating in a research note on Monday, November 4th. Evercore ISI upgraded shares of Cardinal Health from an “in-line” rating to an “outperform” rating and set a $140.00 price target on the stock in a research note on Tuesday, January 7th. StockNews.com lowered shares of Cardinal Health from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd. JPMorgan Chase & Co. upped their price target on shares of Cardinal Health from $132.00 to $142.00 and gave the company a “neutral” rating in a research note on Friday. Finally, Morgan Stanley upped their price target on shares of Cardinal Health from $127.00 to $136.00 and gave the company an “overweight” rating in a research note on Tuesday, December 17th. Four equities research analysts have rated the stock with a hold rating and twelve have given a buy rating to the stock. According to data from MarketBeat, Cardinal Health has a consensus rating of “Moderate Buy” and a consensus price target of $134.64.
Check Out Our Latest Report on Cardinal Health
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
See Also
- Five stocks we like better than Cardinal Health
- How Technical Indicators Can Help You Find Oversold StocksÂ
- MP Materials: Rare Earth Elements Powering the EV Boom
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Verizon’s Turnaround Gains Traction: New Highs Are Likely in 2025
- Golden Cross Stocks: Pattern, Examples and Charts
- Bloom Energy: Powering the Future With Decentralized Energy
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.